ACETAMINOPHEN\NAPROXEN: 23 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
23
Total FAERS Reports
11 (47.8%)
Deaths Reported
11
Hospitalizations
23
As Primary/Secondary Suspect
11
Life-Threatening
11
Disabilities
First Report: 20150701 · Latest Report: 20190610
What Are the Most Common ACETAMINOPHEN\NAPROXEN Side Effects?
#1 Most Reported
Off label use
19 reports (82.6%)
#2 Most Reported
Drug ineffective
18 reports (78.3%)
#3 Most Reported
Synovitis
17 reports (73.9%)
All ACETAMINOPHEN\NAPROXEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 19 | 82.6% | 10 | 10 |
| Drug ineffective | 18 | 78.3% | 9 | 9 |
| Contraindicated product administered | 17 | 73.9% | 9 | 9 |
| Pain | 17 | 73.9% | 9 | 9 |
| Rheumatoid arthritis | 17 | 73.9% | 9 | 9 |
| Swelling | 17 | 73.9% | 9 | 9 |
| Synovitis | 17 | 73.9% | 9 | 9 |
| Condition aggravated | 16 | 69.6% | 8 | 8 |
| Rash | 16 | 69.6% | 8 | 8 |
| Arthralgia | 15 | 65.2% | 6 | 6 |
| Drug intolerance | 14 | 60.9% | 6 | 6 |
| Hepatic enzyme increased | 14 | 60.9% | 6 | 6 |
| Asthenia | 12 | 52.2% | 4 | 4 |
| Gastrooesophageal reflux disease | 11 | 47.8% | 3 | 3 |
| Mobility decreased | 11 | 47.8% | 3 | 3 |
| Muscle spasms | 11 | 47.8% | 3 | 3 |
| Pneumonia | 11 | 47.8% | 3 | 3 |
| Therapeutic response decreased | 11 | 47.8% | 2 | 2 |
| Blood cholesterol increased | 10 | 43.5% | 2 | 2 |
| Infusion related reaction | 10 | 43.5% | 10 | 10 |
Who Reports ACETAMINOPHEN\NAPROXEN Side Effects? Age & Gender Data
Gender: 95.0% female, 5.0% male. Average age: 48.2 years. Most reports from: CA. View detailed demographics →
Is ACETAMINOPHEN\NAPROXEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 1 | 0 | 0 |
| 2019 | 1 | 0 | 0 |
What Is ACETAMINOPHEN\NAPROXEN Used For?
| Indication | Reports |
|---|---|
| Rheumatoid arthritis | 16 |
Official FDA Label for ACETAMINOPHEN\NAPROXEN
Official prescribing information from the FDA-approved drug label.